Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment

NCT02381977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 922

Last updated 2015-03-06

No results posted yet for this study

Summary

PANGEA is an international prospective point prevalence study to describe the epidemiology, interventions, and outcomes in children with acute critical brain disease.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Laerdal Medical

    collaborator INDUSTRY
  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Ericka Fink, MD, MS · 4126925164

Eligibility

Min Age
7 Days
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-10-31
Completion
2014-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381977 on ClinicalTrials.gov